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Some of the physiological properties of the 
cerebral circulation, intracranial pressure and brain 
metabolism, as well as some of the patho-
physiological alterations that we see with various 
types of brain injuries have been discussed in this se-
ries. We are going to see how we can apply some of 
this information clinically. I will begin with a patient. 
A patient, comatose following a severe head in-
jury, is brought into the emergency room. Our 
method of managing these patients has evolved over 
a number of years. Although I shall present the 
procedure to you sequentially, in fact, much is done 
virtually simultaneously. As always, the first thing 
that one must attend to is the airway. The majority of 
comatose head-injured patients, upon admission to 
the emergency ward, have a hyperventilation syn-
drome. It is of primary necessity, in this situation, to 
obtain an arterial blood sample for measurement of 
Pa0 , Paco, and pH. Frequently, the patient is 
hypocapni~, with a Paco, of perhaps 30, and is hypox-
ic as well. In a large series from several clinical units, 
the average Pa0 , of several hundred patients at the 
time of admission was about 65-70 mm Hg-
somewhat hypoxic but generally not severely so. 
How can the patient be hyperventilating, be 
hypocapnic, and hypoxic at the same time? Nearly all 
of these patients have some degree of pulmonary 
arteriovenous shunting but are able to eliminate the 
C02 with their relatively inadequate respirations, 
because C02 diffuses across the alveolar membrane at 
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twenty times the rate of oxygen. At the same time, 
they are not able to get enough 0 2 into the blood . 
Hypoxia and hypocapnia are a very common 
pulmonary syndrome in these patients . 
if the patient looks as though he is severely brain 
injured and is not going to recover soon, we go straight 
to intubation after drawing the arterial blood gas . 
The patient's airway is cleaned and he is then ven-
tilated with an Ambu® bag. By now, someone is taking 
the blood pressure and the heart rate. If the patient 
has a mass lesion, then, in a majority of cases, he has 
a so-called Cushing response consisting of arterial 
hypertension. He may or may not have bradycardia; 
in fact, in our experience, in the acute brain injured 
patient; tachycardia is more common than bradycar-
dia, except in those patients with acute extradural 
hematomas. A decision must be made now as to how 
to manage the patient over the next hour. We give 
dexamethasone (IO mg IV), although I am not at all 
convinced that the patients are benefitted by it. If the 
patient is in extremis, we give 1.5 mg/kg of hyper-
tonic mannitol by IV push, in the hope of buying time 
for angiography. We like to have angiography for all 
of these patients as soon as possible. It must be 
remembered, however, that if done within an hour or 
two of the injury, one may miss the hematoma that is 
in the process of developing. If the neurosurgeon in 
charge feels that there is not time for an angiogram, 
the surgeon may perform exploratory burr holes. We 
avoid this operation if possible, since we feel that 
angiography gives so much information. (The 
technique mentioned in Dr. Vries' presentation of in-
serting a ventricular cannula, injecting some air, and 
then treating the patient immediately, depending 
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upon what that air study shows is impressive; if the 
patient has a shift, take him directly to the operating 
room.) If the patient does not have a mass lesion, a 
Scott cannula is placed through a twist drill hole into 
the anterior horn of the right lateral ventricle, in 
order to measure intracranial pressure continuously. 
If the patient goes to the operating room and has a 
mass lesion removed, the Scott cannula is put into the 
anterior horn of the lateral ventricle at the time of 
surgery. 
The patient is then returned to the neurosurgical 
intensive care unit, where we go through a number of 
procedures which will constitute the bulk of my dis-
cussion. Figure 1 is simply an artist's sketch of the 
Scott cannula in the anterior horn of the right lateral 
ventricle at the level of the coronal suture. Again, 
Figure 2 is an artist's sketch of the patient in the in-
tensive care unit with the head dressing and the Scott 
cannula. The transducer is wrapped in a sterile towel 
because there is a risk of infection from an inside-
o utsi de connection of CSF, and this requires 
meticulous technique. In 350 cases, we have had an 
infection rate of about 2%, which compares favorably 
with Lundberg's 1.6% infection rate in something 
Fig. I 
Fig. 2 
over 1,000 patients with continuous recording of in-
tracranial pressure. We would like to get rid of the in-
tra ventricular cannula, because we consider 2% to be 
still too high, but we do not feel, at this time, that 
there is an adequate solid state transducer for 
measuring intracranial pressure. 
Figure 2 also shows a two channel strip chart 
recorder. One channel records the intracranial 
pressure and the other, systemic arterial pressure 
from a catheter in either the radial or the brachia! 
artery. 
At this point, we prepare to do regional cerebral 
blood flow and metabolism studies. We use the 133Xe 
clearance technique, in order to measure regional 
cerebral blood flow (RCBF). Xenon is injected 
through a catheter placed under fluoroscopic control 
into the internal carotid artery and the xenon is then 
injected as a bolus. The xenon enters the brain, 
diffuses into the brain tissue, and is then cleared from 
the tissue over a period of about 15 minutes. The rate 
of clearance from each region under study determines 
the blood flow; therefore, the faster the rate of 
clearance, the faster the flow. There are a number of 
ways of examining and analyzing these clearance 
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curves. We feel, for our purposes, that eight probes 
for measuring RCBF over each hemisphere are per-
fectly adequate. There are, however, extremely 
sophisticated systems in which it is possible to 
measure the RCBF from as many as 250 regions. 
In addition, a second catheter is placed per-
cutaneously into the jugular vein and passed well up 
into the intracranial space, into the sigmoid sinus, in 
order to obtain a cerebral venous blood sample. 
Periodically during the course of the clinical in-
vestigation, simultaneous samples of blood are taken 
from the artery (from the internal carotid artery, in 
this case) and from the jugular bulb, from which it is 
possible to calculate the cerebral metabolic rate of 
oxygen (CMR0 ). Studies on the cerebral metabolic 
rate of glucose, 'lactate, and pyruvate have been done 
as well. In fact, if one's techniques are sophisticated 
enough, accurate enough, in theory at least, it is pos-
sible to measure anything that the brain utilizes 1:Jy 
measuring the content in both the arterial blood and 
the cerebral venous blood. Here we shall discuss only 
CM Ro,, oxygen utilization . First, we determine the 
0 2 content in both the arterial and venous samples; 
CM R0 is equal to the arteriovenous difference of 
oxygen' content times the mean cerebral blood flow 
divided by 100. 
Table I shows a selection of the normal values, 
such as CBF, approximately 50 ml/100 gm/ min, 
systemic arterial pressure, about 85 . We defined, as 
have others, normal intracranial pressure as less than 
200 mm CSF or less than 15 mm Hg. The cerebral 
perfusion pressure, assuming an ICP of 10, is 75 mm 
Hg, the normal arterial-venous oxygen difference 
(A YD0 ) is 7-a figure to remember. The CMR0 is 
3.5 ml/ 100 gm/ min and the normal values for arte;ial 
blood gases and pH are familiar to you. 
For the sake of example, a single patient will 
now be described in detail. 
A SO-year-old man had been found on the street 
and was brought into the emergency ward comatose; 
he had bruises about the head, indicating that he had 
been bludgeoned, and there were clinical signs point-
ing to a left hemispheric mass with evidence of 
transtentorial herniation. He was given dexa-
methasone and mannitol and was intubated and ven-
tilated with the Ambu® bag. The resident who was 
caring for him felt that he was in extremis, that there 
was not enough time to do an angiogram, despite the 
administration of mannitol; therefore, the patient 
was taken to the operating room for burr holes . 
There was no evidence of an extracerebral 
TABLE I 
Normal values of variables tested 
Variable 
cerebral blood flow (CBF) 
systemic arterial pressure (SAP) 
intracranial pressure (ICP) 
cerebral perfusion pressure (CPP) 
cerebral vascular resistance (CYR) 
arteriovenous blood oxygen content 
(AYDO,) 
cerebral metabolic rate (CMRC,) 
arterial carbon dioxide partial 
pressure (PaCO,) 
arterial oxygen partial pressure 
(PaO,) 
arterial blood acidity (pH) 
Normal Value 
50 ml/100 gm / min 
85 mm Hg 
15mmHg(200 
mm CSF) 
75 mm Hg 
1.70 
7.0 vol % 
3.5 ml/ I 00 gm / min 
40mm Hg 
IOOmm Hg 
7.35 
(Reproduced by permission of the American Association of 
Neurological Surgeons, and the authors, from D. A. Bruce, et al, 
"Physiological Changes in Brain During Coma," J Neurosurg 
38:133, 1973.) 
hematoma; the resident needled the brain one time 
and got no blood, and the Scott cannula was put in 
along with a solid state transducer to measure in-
tracranial pressure. The patient was then taken to the 
angiography suite, where we also do the RCBF and 
metabolism studies. On angiogram, the patient had a 
huge, temporal and deep mass in the hemisphere. The 
Scott cannula was, in this case, placed through a burr 
hole in the lateral ventricle. While the angiogram was 
being developed, we carried out our first RCBF and 
metabolism study. 
Figure 3 demonstrates one of the ways in which 
we display the data. You will note that this patient, 
during the control period, had a mean CBF of 10 
ml/ 100 gm/ min, one-fifth normal and far below that 
ordinarily required to maintain brain function. The 
patient's mean systemic arterial pressure was 135 mm 
Hg, and the mean intracranial pressure extremely 
high at 107 mm Hg, giving the patient then a cerebral 
perfusion pressure (CPP) of 28. Note that at this 
time, the Pa0 is quite adequate at I 04 and the Paco is 
slightly low. The value for CMR0 -0.71-is one-fifth 
normal. One can state as a gener~I rule, with the oc-
casional rare exception, that any patient with CM Ro, 
less than 1.0 probably will not survive. 
The angiogram showed the huge mass which had 
been missed in the operating room with the single 
pass of the needle. The needle was then inserted into 
the region of the mass and we obtained 70 cc of 
blood. A second postevacuation study was per-
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formed, disclosing the reduced mass with the es-
timated increase in CBF from 10 to 18 ml/100 
gm/ min . In the region of the mass, where blood flow 
was virtually obliterated, we had a fourfold increase 
from 6 to 24 ml/ 100 gm/ min. The intracranial 
pressure dropped from 107 to 47 mm Hg following 
evacuation of the mass. If we were measuring only 
the ICP, we might feel we had really accomplished 
something. The systemic arterial pressure, however, 
was being held up by a Cushing response, secondary 
to the intracranial hypertension . Although we 
markedly reduced the intracranial pressure, the blood 
pressure fell equally, and the perfusion pressure went 
only from 28 to 29; despite that, we did increase CBF 
by 8 ml/100 gm/ min. 
Now, however, another problem arose. The 
patient, comatose but showing slight evidence of 
arousal, went from flaccidity to some decerebrate 
posturing; he also began to hyperventilate, driving his 
Paco from 36 down to 23, but, at the same time, he 
developed acute pulmonary edema. Even though he 
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because of the edema, we now saw his Pa0 dropping 
also, from 104 to 75. ' 
Despite the improvement in the CBF and some 
evidence of clinical improvement, the patient's 
CMRo actually fell from 0.71 to 0.39, which is barely 
one-te~th of normal. We tried to raise his blood 
pressure, hoping to improve his perfusion pressure 
and further improve his CBF, then at 18. Figure 4 
shows the response following angiotensin. We 
brought his SAP up to 129 from 76, but the CBF in-
creased only from 18 to 23, because, with the arterial 
hypertension and the edema fluid , the intracranial 
pressure has gone from 47 to 74 mm Hg. In order to 
comprehend the pathophysiology of these patients, 
one must measure nearly all of these variables. 
Despite his marked hypocapnia and hyperventila-
tion, his Pa0 is still only 67 because of his pulmonary 
edema. We decided to give mannitol, and the patient, 
in terms of CBF, responded dramatically; CBF went 
from 23 to 38, perfectly adequate for a normally 
metabolizing brain, and ICP dropped from 74 to 48. 
was hyperventilating and producing hypocapnia, Fig. 4 
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Marked improvement in CBF occurred, despite the 
fact that the patient's perfusion pressure dropped 
from 55 to 46. A change in flow, of course, will occur 
with a change in perfusion pressure or a change in 
resistance or with a change in both, and, in this case, 
it is quite clear that the mannitol has reduced the 
edema, thereby opening up the microcirculation and 
permitting a marked improvement in CBF, despite 
there being no significant change in the patient's 
CPP. The Pa0 and Paco were the same; the CMR0 
was fluctuating somewh~t. ' 
We continued to battle his intracranial pressure, 
which, however, continued to rise, and finally, as is 
the rule in these cases, the intracranial pressure 
equaled the blood pressure. At this point, the phenome-
non of nonfilling of the cerebral circulation upon 
angiography or injection of 133X became evident. In 
this situation, if one injects radio-opaque media into 
the carotid artery, it will rise up into the internal 
carotid (sometimes to the level of the siphon) and 
then stop. A film taken 30 seconds or a minute later 
will show the opaque dye still sitting in the carotid 
artery, none having entered the intracranial space, 
due to the fact that ICP equals SAP and, therefore, 
CPP is zero. When this occurred in our patient, we 
decided he obviously had all of the clinical criteria of 
brain death. We decided, however, to manipulate the 
blood pressure with a vasopressor agent, Levophed®, 
to see whether we could possibly reestablish a perfu-
sion pressure. These primary changes in systemic 
arterial pressure, produced by altering the rate of drip 
of a vasopressor agent, produced precisely equal 
changes in the ICP. There was no way to reestablish 
perfusion pressure by manipulating the arterial 
pressure. In this patient who had a severe and, as it 
turned out, irreversible brain injury, we were, by 
various types of manipulations, able to raise his CBF 
to something approaching a normal range, but too 
late, and the patient died shortly after this study. 
Now, just a few comments on intracranial 
pressure. Until the publication of Lundberg's land-
mark monograph from the University of Lund in 
Sweden in 1960, we generally thought of ICP as being 
a steady phenomenon; intracranial pressure had been 
measured only through the lumbar subarachnoid 
space in the vast majority of patients. In 1963, we 
demonstrated in experimental animals (using a slowly 
expanding extradural balloon in the monkey), that 
when the intracranial pressure rises by virtue of ex-
pansion of a mass, a dissociation occurs invariably, 
between the supratentorial pressure and the pressure 
of the lumbar subarachnoid space. Finally, with the 
slow expansion of the balloon, when the intracranial 
pressure reached the level of the blood pressure in the 
monkey, lumbar subarachnoid pressure was normal. 
We demonstrated that this also occurs in man. The 
higher the intracranial pressure, the greater the brain 
swelling, the less likely it is that the lumbar sub-
arachnoid pressure will reflect that increased in-
tracranial pressure. Many times in man, lumbar sub-
arachnoid pressure is normal when the intracranial 
pressure is from 50-100 mm Hg. It follows, therefore, 
that one cannot use lumbar subarachnoid pressure to 
determine the actual pressure within the intracranial 
space. All pressure measurements today are done 
directly from the intracranial space by one method or 
another. 
Lundberg then demonstrated that in many 
patients, intracranial pressure is not a steady 
phenomenon; in fact, there are tremendous fluc-
tuations in pressure. He described what he called "A 
waves or plateau waves, B waves, and C waves." For 
the most part, these waves appear to be rather in-
nocuous, there being, usually, no indication of 
neurological deterioration. With the extremely 
dangerous plateau wave, the intracranial pressure is 
reasonably steady, at first, but then fluctuates, and 
finally, inexorably rises-a terminal pressure wave. 
Figure 5 summarizes work that we did some 10 
or 11 years ago. It is a very simple figure but quite im-
portant. This is the volume pressure graph within the 
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intracranial space, actually taken from a series of 
monkeys. We put in an extradural balloon, and then 
slowly inflate it at a rate of 1 ml/min, while we 
measure the intracranial pressure. Up to a volume of 
about 5 ml in the balloon, there is no significant 
change in intracranial pressure. Why is this? Because 
the intracranial space contains displaceable fluid, 
mainly in the form of CSF but also, to some extent, in 
the form of intravascular blood. Since we are dealing 
with a cavity that is nondistensible, which is filled to 
capacity with a noncompressible fluid and solid 
material, it follows that if indeed we had a completely 
closed system, that is, if we had a sphere made of 
bone filled to capacity with water, and we attempted 
to inject additional water into that cavity, we could 
probably inject no more than 0.1 ml, in the case of the 
monkey; we would get a tremendous rise in in-
tracranial pressure, simply because we cannot stretch 
the shell. We cannot compress the fluid. That is not 
the case in life. We can actually put 5 ml of fluid into 
this monkey's skull (total capacity of 100 ml), 
because of spatial compensation. It means that up to 
a value of about 5 ml, for every 1 ml that we are put-
ting into the balloon, we are expressing I ml of CSF 
or blood. Then we pass from this period of spatial 
compensation, the horizontal portion of the volume 
pressure graph, onto the vertical portion. Note here 
that between a balloon volume of 7 and 8 ml, the in-
tracranial pressure rises 75 mm Hg. Thus, in the case 
of those patients with pressure waves, those who have 
any kind of mass lesion or brain edema, the bulk of 
them are somewhere on the vertical part of the graph. 
The pressure waves are due to spontaneous 
alterations in cerebral blood volume. The pressure 
waves are reflecting alternating vasodilatation and 
vasoconstriction of the cerebral vascular bed. We do 
not know the reason for this. The vasodilatation 
produces a slight increase in cerebral blood volume. 
That slight increase, however, when the patient is on 
the vertical portion of the volume pressure graph, will 
produce a tremendous change in pressure. The 
patient who presents with a longstanding space-
occupying mass, chronic subdural hematoma or 
meningioma, who has now reached the limits of his 
period of spatial compensation, therefore, may have 
few signs or symptoms, but he is sitting on a time 
bomb as it were. When he goes to sleep, for example, 
he becomes a little hypoxic and hypercapnic. We 
recorded many of these patients in sleep, and indeed, 
their intracranial pressure may rise astonishingly dur-
ing sleep, simply because of a little bit of vasoqilata-
tion from the hypercapnia. It follows as well, that if 
one is treating a patient who is on the vertical portion 
of the curve, it is necessary to remove only a small 
portion of any one of the volumes within the in-
tracranial space in order to drop the pressure. We 
have many patients who have had pressure of 80-90 
mm Hg. The removal of no more than 2 ml from the 
ventricle will drop the pressure down to 20-30 mm 
Hg, because they are falling on an extremely sharp 
vertical portion of the curve. 
What constitutes a critical level of intracranial 
pressure for brain function? I have no idea, because it 
varies so much from patient to patient. The more the 
brain itself is damaged, that is, the more the edema, 
the more contusion, then the less tolerant that patient 
is of intracranial hypertension. We have many 
patients, for example, who would not tolerate an ICP 
above 25-30 mm Hg; they would obtund, develop a 
hemiparesis. When we then lowered the pr~ssure to 
10-15 mm Hg, they would improve. Patient~ who do 
not have brain damage but, nevertheless, have in-
tracranial hypertension, will often tolerate extremely 
high levels of intracranial pressure. We have seen a 
young woman with severe hydrocephalus from a 
cerebellar hemangioblastoma. She was neurologically 
normal, except for minimal ataxia and some 
papilledema-her brain was normal. We recorded 
her intracranial pressure continuously through the 
Scott cannula and then slowly drained the ventricles 
over a period of two or three days, as we always do 
before doing posterior fossa surgery in these people. 
We also recorded and checked the: systemic arterial 
pressure from the catheter in the the radial artery. 
For very long periods of time, the patient had a CPP 
as low as 6 mm Hg, the mean intracranial pressure, 
85, and the mean arterial pressure, 91; this particular 
time, she was in the intensive care unit, sitting up 
reading a magazine, completely asymptomatic. This 
is an indication of the phenomenal degree of 
autoregulation that can be seen clinically. 
If a hypertonic solution such as mannitol has 
been given to a patient without causing reduction in 
his intracranial hypertension, we might conclude that 
mannitol has been of no benefit, and not give it to 
that patient again. We might say that the patient is 
refractory to mannitol. 
Often this is not the case, and the patient im-
proves despite no major ICP fall. How can this be? 
We postulate that mannitol has reduced edema. 
Reduction of the water content in the brain alone, 
obviously, should result in decrease in intracranial 
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pressure, but if one has compression of the microcir-
culation of the capillary bed in the venules by the 
edema, and one reduces the edema, what is going to 
happen to the cross-sectional area of the vascular 
bed? It will enlarge as the compression is relieved. 
Our guess is that as we remove the edema from the 
brain with the mannitol, the edema is being replaced 
by intravascular blood secondary to expansion of the 
cerebral vascular bed. The net intracranial volume 
remains the same, and intracranial pressure does not 
decrease. What these data clearly show is that one 
cannot use intracranial pressure alone to determine 
whether or not mannitol has had a beneficial effect on 
the patient; one must, unfortunately, measure CBF. 
The first indication for the use of mannitol 
therapy, in our opinion, is for reducing brain bulk 
during craniotomy, and second, for reducing ICP to 
permit time for emergency cerebral angiography. The 
third indication for its use is control of ICP during 
continuous recording of /CP. I believe that the inter-
mittent, or perhaps even the continuous, use of man-
nitol in these patients without continuous recording 
of intracranial pressure is very dangerous, because if 
the patient has a hemorrhage, a hematoma that is ex-
panding, reduction of the intracranial pressure causes 
further expansion of the hematoma; then, as the os-
motic gradient is reversed, fluid comes back into a 
space reduced by the enlargement of the hematoma. 
This kind of situation can kill the patient quickly. 
I will conclude by saying that I think the con-
tinuous measurement of intracranial pressure in the 
proper management of patients not only with severe 
head injuries, but with severe brain insults as well, 
has passed now from being a research tool to a virtual 
necessity. I cannot say the same thing, yet, about 
measurements of RCBF and cerebral metabolism, as 
we are now caught in an ethical bind. We have four 
or five RCBF runs, or consecutive studies, done on 
patients over several hours. Rarely have we been able 
to repeat these studies, because we did not feel justi-
fied in repuncturing the carotid artery, unless it was 
necessary to do an angiogram on the patient. My 
contention is that we would learn much more from 
one patient with severe brain injury who has ten CBF 
studies over a period of several days than we would 
learn from ten patients who have one study each. In 
order to prove that these techniques, which are ex-
pensive and time consuming, are really going to help 
us in the management of these patients, we now need 
to have a reliable noninvasive technique for doing 
RCBF. These techniques are now available, par-
ticularly in the form of either inhalation or in-
travenous injection of 133Xe, but the mathematics are 
extremely complex and must be done with a 
laboratory computer, but I think they are promising. 
In our neurosurgical intensive care unit, we are just 
beginning to compare the carotid injection of xenon 
with the inhalation of xenon, to see how well the 
results correspond in our patients with severe brain 
injuries. Ifwe obtain a reliable noninvasive technique 
and can repeat the RCBF studies every hour, day and 
night for as long as we wish, with no harm whatso-
ever to the patient, we will then be able to provide 
the intensive treatment for these patients and the 
evaluation of the therapy to which we have looked 
forward for so long. 
